DBJ Capital

DBJ Capital Co., Ltd., established in June 2010, is a corporate venture capital investment arm of the Development Bank of Japan, located in Tokyo. The firm emerged from the integration of two venture capital entities within the DBJ Group. DBJ Capital focuses on investing in companies that leverage new technologies and innovative business models across various industries to enhance their competitive edge in the global market. The company offers tailored investment solutions, including equity investments and financing options, utilizing the extensive resources of the DBJ Group. In addition to capital investment, DBJ Capital provides hands-on support to help startups commercialize their intellectual property and technologies developed by firms, research labs, and universities. By fostering the growth of the companies it invests in, DBJ Capital aims to contribute to Japan's economic revival and stimulate the creation of new industries within the country.

Daiki Ito

Investment Manager

Akama Sho

Senior Investment Manager

Haruhiko Uchiyama

President and CEO

Past deals in Japan

REJECT

Series B in 2024
REJECT is an esports and entertainment organization that specializes in the management and operation of professional esports teams. Founded in 2018 and based in Minato, Japan, REJECT focuses on fostering communication and creativity within the esports community. The organization provides comprehensive team management services, which include the planning and execution of campaigns, events, and exhibitions. By combining esports with cultural elements, REJECT aims to enhance the domestic esports market and elevate players to national prominence, bridging gaps across various demographics and fostering inclusivity.

nearMe

Series C in 2024
NearMe Inc. is a Tokyo-based company that specializes in a mobile application designed for taxi ride-sharing services. Founded in 2017, the application facilitates instant matching of individuals traveling in the same direction, addressing inefficiencies in transportation and commuting. By enabling users to share taxi rides in real time, NearMe aims to improve the commuting experience and promote a more sustainable community. The platform addresses social inefficiencies by connecting users with similar travel interests, ultimately contributing to a more comfortable and efficient commuting solution.

Cellusion

Series C in 2023
Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.

Kyoto Fusioneering

Series C in 2023
Kyoto Fusioneering is a privately funded technology start-up established in 2019 and based in Kyoto, Japan. The company specializes in developing advanced technologies for commercial fusion reactors, including gyrotron systems, tritium fuel cycle technologies, and breeding blankets for tritium production and power generation. By providing innovative solutions such as liquid metal and molten salt systems, as well as tritium treatment and high-frequency microwave gyrotrons, Kyoto Fusioneering aims to support both public and private fusion developers globally. The company's efforts contribute to the acceleration of fusion energy as a sustainable and carbon-free power source for the future.

Techtouch

Series B in 2023
Techtouch, Inc. is a Tokyo-based company founded in 2018 that specializes in developing TechTouch, a digital transformation platform designed to improve operational efficiency for businesses. Its software provides an intuitive website user manual by overlaying explanatory guidance directly onto existing web systems through a browser plug-in and server-side integration. This approach allows for real-time navigation assistance, minimizing the challenges associated with complex system operations. By enhancing system education for employees and promoting better utilization of web resources, Techtouch aims to reduce operational burdens and streamline business processes.

Spacely

Venture Round in 2022
Spacely, Inc. is a cloud software company based in Tokyo, Japan, that specializes in the creation and editing of virtual reality (VR) content. Founded in 2013 and previously known as 3D Stylee until its rebranding in 2018, Spacely offers an intuitive platform that allows users to manage VR web content using photos captured with 360-degree cameras. The software caters to various industries, including real estate, tourism, and retail, enabling businesses to develop their own VR services through an application programming interface (API). By simplifying the VR content creation process, Spacely aims to provide a seamless experience for users looking to engage audiences through immersive digital experiences.

Cellusion

Venture Round in 2022
Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.

Sprocket

Series C in 2021
Sprocket Inc., founded in 2014 and based in Tokyo, Japan, specializes in developing customer development applications. The company offers a web-based platform that enhances customer service by optimizing conversion rates through the analysis of user behavior. Sprocket's solution allows businesses to implement a continuous improvement cycle by formulating hypotheses, conducting tests, and evaluating results based on key performance indicators and goals. Its tools are designed to foster long-term relationships between companies and their end users, improving the overall customer experience across various industries. The platform is compatible with both Android and iOS, making it accessible to a wide range of users.

Kyulux

Series B in 2021
Kyulux, Inc. is a company based in Fukuoka, Japan, specializing in the research and development of organic electroluminescence materials for organic light-emitting diode (OLED) displays and lighting. Founded in 2015, Kyulux focuses on developing thermally activated delayed fluorescence (TADF) technology and offers a product known as Hyperfluorescence, which combines TADF with fluorescence emitters to enhance emission efficiency. The company holds an extensive intellectual property portfolio related to TADF, largely developed through collaborations with Kyushu University and industrial partners over the past seven years. By providing these innovative OLED materials, Kyulux enables manufacturers in the display and lighting sectors to create cost-effective, durable, and efficient products without relying on rare metals.

nearMe

Series A in 2020
NearMe Inc. is a Tokyo-based company that specializes in a mobile application designed for taxi ride-sharing services. Founded in 2017, the application facilitates instant matching of individuals traveling in the same direction, addressing inefficiencies in transportation and commuting. By enabling users to share taxi rides in real time, NearMe aims to improve the commuting experience and promote a more sustainable community. The platform addresses social inefficiencies by connecting users with similar travel interests, ultimately contributing to a more comfortable and efficient commuting solution.

Alivas

Series A in 2020
Alivas Inc. is a medical company based in Hongo, Tokyo, Japan, that specializes in developing therapeutic medical devices aimed at treating refractory constipation. Founded in 2017, Alivas emerged as a joint venture between Stanford University and the University of Tokyo, leveraging the Japan Biodesign program to foster innovative solutions in medical device creation. The company's primary focus is on addressing intractable chronic constipation, providing patients with effective treatment options to alleviate their condition and improve their quality of life.

Techtouch

Series A in 2020
Techtouch, Inc. is a Tokyo-based company founded in 2018 that specializes in developing TechTouch, a digital transformation platform designed to improve operational efficiency for businesses. Its software provides an intuitive website user manual by overlaying explanatory guidance directly onto existing web systems through a browser plug-in and server-side integration. This approach allows for real-time navigation assistance, minimizing the challenges associated with complex system operations. By enhancing system education for employees and promoting better utilization of web resources, Techtouch aims to reduce operational burdens and streamline business processes.

Photoruction

Venture Round in 2020
Photoruction, Inc. is a Tokyo-based company that specializes in providing internet services tailored for the construction industry. Founded in 2016, Photoruction offers a cloud platform designed for construction photography and civil engineering support. Its flagship product facilitates the documentation of construction processes through an app that allows architects, construction teams, and landowners to capture, save, and share blueprints and photographs. The platform digitizes traditionally paper-based workflows, automates the organization of albums and photos, and enhances data sharing capabilities. Additionally, Photoruction develops an AI-driven engine that interprets information from drawings and photographs, aiming to streamline various phases of construction projects, from design to procurement. This technology enables clients to significantly reduce operational time and enhance productivity.

TVISION INSIGHTS

Venture Round in 2020
TVISION INSIGHTS is a company that measures the "viewing quality" of television. Utilizing state-of-the-art human body recognition technology developed by TVISION, it is rare in the world to acquire TV viewing status in the living room and convert it into data, and a very unique data set that does not exist is founded It has been acquired and accumulated since then. Currently, we have expanded our bases globally and have expanded to Tokyo, Boston and New York. While challenging challenges in different markets,we are continuing to grow rapidly to realize the original potential of TV.

Ginco

Series A in 2020
Ginco Inc. is a Tokyo-based company established in 2017 that specializes in blockchain technology and cryptocurrency solutions. Its primary product is the Ginco mobile cryptocurrency wallet, which enables users to manage various digital assets securely through multi-signature technology. The wallet supports multiple cryptocurrencies, including Bitcoin, Ethereum, and Ripple, and is designed to accommodate both hot and cold wallet functionalities. In addition to its wallet services, Ginco offers crypto mining, enterprise wallet solutions, and node management services. The company's mission is to reshape the relationship between individuals and their assets by leveraging blockchain technology, with plans to expand into decentralized exchanges and other facets of the evolving digital currency ecosystem.

Kringle Pharma

Venture Round in 2020
Kringle Pharma, Inc. is a biopharmaceutical company based in Ibaraki, Japan, founded in 2001. The company focuses on the research and development of hepatocyte growth factor (HGF) and its applications in treating various medical conditions. Kringle Pharma's HGF products aim to promote regenerative healing in liver cells and other organs, addressing acute spinal cord injury, amyotrophic lateral sclerosis (ALS), acute kidney injury, and vocal fold scars. Additionally, the company develops NK4, a bi-functional molecule that serves as an HGF antagonist, inhibiting tumor cell invasion and metastasis while exhibiting antiangiogenic properties. Kringle Pharma's pipeline includes recombinant human HGF for acute renal failure and skin ulcers, as well as NK4-based therapies for cancer treatment.

Cellusion

Series A in 2020
Cellusion Inc. is a Tokyo-based regenerative medicine company specializing in the research and development, manufacturing, and sales of induced pluripotent stem cell-derived corneal endothelial cells aimed at treating bullous keratopathy. Founded in 2015, Cellusion focuses on providing innovative solutions for cell transplantation, utilizing a mass culture system for corneal endothelial cells derived from iPS cells. This approach allows healthcare professionals to improve vision in patients suffering from bullous keratopathy by injecting the cell substitutes, which replace damaged corneal tissue, thereby enhancing the quality of life for affected individuals.

nearMe

Series A in 2019
NearMe Inc. is a Tokyo-based company that specializes in a mobile application designed for taxi ride-sharing services. Founded in 2017, the application facilitates instant matching of individuals traveling in the same direction, addressing inefficiencies in transportation and commuting. By enabling users to share taxi rides in real time, NearMe aims to improve the commuting experience and promote a more sustainable community. The platform addresses social inefficiencies by connecting users with similar travel interests, ultimately contributing to a more comfortable and efficient commuting solution.

RT Corporation

Series B in 2019
RT Corporation, based in Chiyoda ku, Japan, develops and sells a range of robots and robotic components, focusing on both military and service applications. Its product lineup includes specialized robots such as army-type models and micro mouse robots, including the CRANE-X7, AI Chip V3, and GAINER mini. The company also offers a variety of services, encompassing robot development, hardware and software creation, compound biopsy services, and contract manufacturing. Established in 2005, RT Corporation aims to meet the growing demands for service robots in various domestic and international markets, leveraging advancements in artificial intelligence to enhance its offerings.

Motion Lib

Venture Round in 2019
Motion Lib, Inc., founded in 2016 and based in Kawasaki, Japan, specializes in haptic technology aimed at enhancing collaboration between humans and robots. The company, originally known as Undou Sekkei Kenkyuusho Limited until its rebranding in April 2017, has developed a specialized chip that estimates and calculates the repulsive force experienced when objects are touched, based on the load force applied to robotic motors. This innovation enables machines to interact more effectively with their environment, expanding their operational capabilities and contributing to increased productivity in various sectors.

GITAI

Series A in 2019
GITAI Inc. is a leading space robotics company based in Tokyo, Japan, established in 2016. The firm specializes in manufacturing humanoid telepresence robots to assist with tasks related to space exploration, particularly within space stations and lunar development. GITAI's product lineup includes the G1 robot, designed for general-purpose automation, the S1 robot for specific task automation, and the H1 manipulation system for remote operation of robots in space. By providing a reliable alternative to human labor, GITAI aims to enhance safety, improve efficiency, and significantly reduce operational costs in space activities. Their technology is intended to facilitate the construction and maintenance of satellites, space stations, and future habitats on the Moon and Mars, ultimately enabling more sustainable and cost-effective space exploration.

Spacely

Series A in 2019
Spacely, Inc. is a cloud software company based in Tokyo, Japan, that specializes in the creation and editing of virtual reality (VR) content. Founded in 2013 and previously known as 3D Stylee until its rebranding in 2018, Spacely offers an intuitive platform that allows users to manage VR web content using photos captured with 360-degree cameras. The software caters to various industries, including real estate, tourism, and retail, enabling businesses to develop their own VR services through an application programming interface (API). By simplifying the VR content creation process, Spacely aims to provide a seamless experience for users looking to engage audiences through immersive digital experiences.

Kyulux

Series B in 2019
Kyulux, Inc. is a company based in Fukuoka, Japan, specializing in the research and development of organic electroluminescence materials for organic light-emitting diode (OLED) displays and lighting. Founded in 2015, Kyulux focuses on developing thermally activated delayed fluorescence (TADF) technology and offers a product known as Hyperfluorescence, which combines TADF with fluorescence emitters to enhance emission efficiency. The company holds an extensive intellectual property portfolio related to TADF, largely developed through collaborations with Kyushu University and industrial partners over the past seven years. By providing these innovative OLED materials, Kyulux enables manufacturers in the display and lighting sectors to create cost-effective, durable, and efficient products without relying on rare metals.

Trajectory

Venture Round in 2019
Trajectory, Ltd. is a Tokyo-based company established in 2018 that specializes in the research and development of control systems for unmanned aerial vehicles (UAVs). The company has created an AI Traffic Control system that facilitates fully autonomous navigation for drones. Its innovative technology allows for the automated generation of flight routes for multiple UAVs, enabling simultaneous deployment and operation. By providing clients with a safe and accessible environment for UAV usage, Trajectory aims to address various operational challenges associated with unmanned aircraft.

Medical Care Service

Acquisition in 2018
Medical Care Service Company Inc. is a medical care service provider based in Saitama, Japan, specializing in elderly care, particularly for individuals with dementia. Founded in 1999, the company operates over 210 group homes and seven paid nursing homes, offering a range of services including nursing care, functional training, and assistance with daily living activities such as bathing, meal preparation, and personal care. In addition to residential care, Medical Care Service provides day care services, home care support, and visiting nursing services. The company also engages in the sale and rental of welfare equipment, such as wheelchairs and walking frames, and is involved in personnel recruitment and placement within the healthcare sector. As of 2018, Medical Care Service operates as a subsidiary of Gakken Holdings Co. Ltd.

Alivexis

Series A in 2018
Alivexis is a preclinical stage drug discovery company based in Tokyo, specializing in the rapid design and generation of small molecule clinical candidates aimed at addressing high-value disease targets. The company leverages advanced computational drug discovery techniques and unique biological insights to accelerate the development of new medicines. Its international team consists of experts in drug design and disease biology, drawing on extensive research and development experience from global pharmaceutical and biotechnology firms. Alivexis's platform is designed to enhance biotechnological research, ultimately enabling healthcare professionals to deliver effective treatments to patients with unmet medical needs.

Curadim Pharma

Venture Round in 2018
Curadim Pharma a pipeline-driven biotech company that discovers unutilized innovative drug seeds in Japan.

TL Genomics

Venture Round in 2018
TL Genomics Co., Ltd., founded in 2015 and based in Tokyo, Japan, specializes in DNA testing services with a focus on prenatal diagnosis. The company has developed a unique technology that isolates fetal nucleated red blood cells from maternal blood, allowing for non-invasive examination of the fetal genome. This innovative approach facilitates early and definitive diagnosis of fetal chromosomal disorders during pregnancy. Additionally, TL Genomics offers laminated microfluidic devices that enhance the efficiency of cell fractionation, thereby supporting healthcare providers in ensuring safe pregnancies for their patients.

Spacely

Seed Round in 2018
Spacely, Inc. is a cloud software company based in Tokyo, Japan, that specializes in the creation and editing of virtual reality (VR) content. Founded in 2013 and previously known as 3D Stylee until its rebranding in 2018, Spacely offers an intuitive platform that allows users to manage VR web content using photos captured with 360-degree cameras. The software caters to various industries, including real estate, tourism, and retail, enabling businesses to develop their own VR services through an application programming interface (API). By simplifying the VR content creation process, Spacely aims to provide a seamless experience for users looking to engage audiences through immersive digital experiences.

Megakaryon

Series C in 2017
Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.

meleap

Series A in 2017
Meleap Inc. is a Japanese company based in Minato, established in 2014, that specializes in developing sports gaming platforms using augmented reality (AR) technology. The company is best known for its flagship product, HADO, a new sport in which players wear head-mounted displays and armband sensors to engage in competitive gameplay. In HADO, participants can use virtual "energy balls" and "shields" to score points in a three-on-three format. The immersive experience is designed to provide an innovative and entertaining alternative to traditional sports, showcasing the potential of motion sensors and AR in the gaming industry. Meleap's offerings include various game formats such as monster battle, shooting, kart racing, and play space, catering to a diverse audience seeking engaging and interactive experiences.

Timers

Venture Round in 2017
Timers offers a range of mobile applications based on match-making for singles. The company is based in Tokyo, Japan.

Truss

Venture Round in 2017
Truss is a Tokyo-based company that offers an online platform for comparing building materials, serving the construction industry. The platform provides comprehensive information about various building materials from multiple manufacturers, allowing users to search and compare products based on specific parameters such as performance metrics and required conditions. By consolidating building material data into a user-friendly database, Truss facilitates informed decision-making for all parties involved in construction projects, streamlining the selection and management of materials.

RT Corporation

Series A in 2017
RT Corporation, based in Chiyoda ku, Japan, develops and sells a range of robots and robotic components, focusing on both military and service applications. Its product lineup includes specialized robots such as army-type models and micro mouse robots, including the CRANE-X7, AI Chip V3, and GAINER mini. The company also offers a variety of services, encompassing robot development, hardware and software creation, compound biopsy services, and contract manufacturing. Established in 2005, RT Corporation aims to meet the growing demands for service robots in various domestic and international markets, leveraging advancements in artificial intelligence to enhance its offerings.

Smart Trade

Seed Round in 2017
Smart Trade is an information technology company that provides a web-based platform designed for investors. Its platform act as an online marketplace for investment strategy environment software. Smart Trade allows software developers to sell and upload their software online. The company was founded in 2016 and headquartered in Tokyo, Japan.

ReasonWhy

Venture Round in 2017
ReasonWhy Inc. is a Japan-based company founded on July 7, 2011, that specializes in healthcare IT services. The company offers four main services: Whytlink, a social network designed for doctors; Findme, an online second-opinion service that connects patients with doctors from the Whytlink network; WhytPlot, a big-data analysis tool aimed at pharmaceutical manufacturers in Japan; and yourHospital, a search engine that helps users find specialist hospitals. Through these services, ReasonWhy seeks to enhance communication and information sharing within the medical community while improving patient access to healthcare resources.

Coconala

Venture Round in 2017
Coconala operates a website to buy and sell knowledge, skills and, experience from users who are willing to teach. It provides a broad range of services for sellers including fortune-telling, relieving mental anguish, illustration, design, consultation for hobbies, and travel destinations. The company was founded in 2012 and is based in Japan.

Magellan Systems Japan

Venture Round in 2017
Magellan Systems Japan, Inc. specializes in the research, development, and licensing of high-precision satellite positioning systems. Founded in 1987 and headquartered in Amagasaki, Japan, the company offers a range of products including software-based global positioning systems (GPS), multi-frequency global navigation satellite systems (GNSS), real-time kinematic systems, and inertial measurement systems. Additionally, it provides GPS timing solutions and autonomous ephemeris prediction services. The company is involved in the import and sale of GNSS-related products, as well as the development of advanced processing technologies. With a focus on delivering accurate location information and time calculations, Magellan Systems Japan plays a significant role in the satellite navigation sector.

Kringle Pharma

Venture Round in 2016
Kringle Pharma, Inc. is a biopharmaceutical company based in Ibaraki, Japan, founded in 2001. The company focuses on the research and development of hepatocyte growth factor (HGF) and its applications in treating various medical conditions. Kringle Pharma's HGF products aim to promote regenerative healing in liver cells and other organs, addressing acute spinal cord injury, amyotrophic lateral sclerosis (ALS), acute kidney injury, and vocal fold scars. Additionally, the company develops NK4, a bi-functional molecule that serves as an HGF antagonist, inhibiting tumor cell invasion and metastasis while exhibiting antiangiogenic properties. Kringle Pharma's pipeline includes recombinant human HGF for acute renal failure and skin ulcers, as well as NK4-based therapies for cancer treatment.

Karydo Therapeutix

Seed Round in 2016
Karydo Therapeutix, Inc. is a Tokyo-based company that specializes in developing advanced technologies for early disease detection and prevention. Utilizing its iOrgans technology platform, the company focuses on various sub-technologies, including Reverse-iOrgans, Forward-iOrgans, and Drug-iOrgans. These technologies leverage indicators to identify the earliest signs of diseases, anticipate their progression, and assess drug side effects or new applications for existing medications. By employing data science and artificial intelligence, Karydo Therapeutix visualizes the interconnectedness of organs and their functions, creating a digital twin of the body that aids in predicting future health states. Founded in 2015, the company aims to enhance the efficiency of drug development and improve health outcomes through precision research and development.

Kyulux

Series A in 2016
Kyulux, Inc. is a company based in Fukuoka, Japan, specializing in the research and development of organic electroluminescence materials for organic light-emitting diode (OLED) displays and lighting. Founded in 2015, Kyulux focuses on developing thermally activated delayed fluorescence (TADF) technology and offers a product known as Hyperfluorescence, which combines TADF with fluorescence emitters to enhance emission efficiency. The company holds an extensive intellectual property portfolio related to TADF, largely developed through collaborations with Kyushu University and industrial partners over the past seven years. By providing these innovative OLED materials, Kyulux enables manufacturers in the display and lighting sectors to create cost-effective, durable, and efficient products without relying on rare metals.

NORMEE

Venture Round in 2016
NORMEE Limited specializes in palm recognition technology that allows users to unlock their devices through unique palm patterns, including lines, ridges, veins, and capillaries. Utilizing the built-in camera of smartphones and tablets, NORMEE's system provides accurate authentication using standard visible-spectrum cameras. Founded in February 2005 and based in Tokyo, Japan, the company focuses on developing mobile biometrics technology that supports hybrid biometric authentication tailored to different operating environments. Formerly known as Universal Robot Co., Ltd., NORMEE aims to enhance security and user convenience in mobile device access.

ClipLine

Seed Round in 2016
ClipLine is a provider of a video-based management platform aimed at enhancing organizational execution for businesses with multiple locations in Japan and internationally. Launched in October 2014, the service initially focused on the restaurant industry but has since expanded to various sectors, including nursing care, retail, transportation, and manufacturing. The platform facilitates digital transformation by improving organizational structure and communication, allowing clients to monitor quality and enhance sales effectively. Currently, ClipLine serves around 15,000 locations and approximately 420,000 users, demonstrating its widespread adoption across diverse fields.

On-Chip Biotechnologies

Venture Round in 2015
On-Chip Biotechnologies Co., Ltd. is a Tokyo-based company specializing in the development and manufacturing of advanced biosafety flow cytometers and related medical devices. Founded in 2005, the company offers innovative products such as the FISHMAN-R analyzer, which utilizes a microfluidics chip for flow cytometry. This analyzer is capable of detecting and analyzing specific bacteria and cells through the Flow-FISH method, accommodating particles ranging from 0.5μm to 20μm in size and allowing for analysis of small sample quantities. In addition to flow cytometry, On-Chip Biotechnologies produces cell sorters and droplet generators. Their cell sorting device is designed to provide damage-free and contamination-free cell separation by employing a liquid transfer system on a disposable microchannel chip, thus reducing sorter-induced cellular stress.

A-Traction

Seed Round in 2015
A-Traction Inc., founded in 2015 and based in Kashiwa, Japan, specializes in the development of surgical robots designed to enhance laparoscopic surgery. The company focuses on creating medical devices that act as collaborative partners for surgeons during operations, promoting safer and more effective surgical procedures. A-Traction's innovative concept, known as ANSUR, allows the robotic system to assist surgeons by moving in tandem with their actions, thereby improving the overall surgical experience. The company's mission is to commercialize advanced surgery support robots that leverage their lightweight design to provide high-quality surgical outcomes for a greater number of patients.

SmileWorks

Venture Round in 2015
SmileWorks Inc. designs and develops cloud- and web-based application services for ministries. It was founded in 2003 and is based in Hirata, Shimane, Japan.

Gengo

Series C in 2015
Gengo’s unique platform consists of a diverse and growing community of more than 18,000 qualified translators from 114 countries working across 37 languages and 64 language pairs. The professional human translation platform represents a huge leap in quality compared to machine translation, while enjoying faster delivery times than traditional service providers. Through its web offering and open API, Gengo enables businesses of any size to quickly and easily connect with a global audience at scale. Clients and partners include JTB, TripAdvisor, BuzzFeed, Rakuten and Vestiaire Collective; a more complete list can be found at https://gengo.com/customers/ Founded in 2008, Gengo is headquartered in Tokyo, Japan with an office in Silicon Valley. To learn more about Gengo, visit www.gengo.com

Megakaryon

Series B in 2015
Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.

Cyfuse Biomedical

Venture Round in 2015
Cyfuse Biomedical K.K. is a biotechnology company based in Tokyo, Japan, that specializes in the research, development, and commercialization of tissue fabrication systems and cell-based products. Founded in 2010, the company offers 3D BioFabrication systems that utilize robotic technology to assemble spheroids into customized 3D shapes, providing innovative solutions for cell delivery in research and therapeutic applications. Cyfuse develops and licenses 3D tissue products for therapeutic use and engages in contract manufacturing for research purposes. The applications of its products include blood vessel grafts for hemodialysis access and coronary artery bypass grafts, cardiac grafts for drug toxicology and myocardial infarction therapy, cartilage grafts for surgical reconstruction, and hepatocyte grafts for drug metabolism studies and hemophilia treatment. Cyfuse Biomedical serves various research and development institutes, including universities, and has established a strategic partnership with Shibuya Kogyo Co., Ltd.

Lacras

Venture Round in 2014
Lacras Corporation, founded in 2005 and based in Tokyo, Japan, specializes in human resource management solutions. The company offers web-based HR cloud services and business process outsourcing (BPO) services that assist organizations in optimizing their HR operations. Lacras provides a comprehensive personnel database that facilitates the management of employee information, talent management functions, and the integration of data with clients' systems. This enables businesses to efficiently collect and manage personnel information, thereby streamlining their HR processes and improving overall operational effectiveness.

Jtower

Venture Round in 2014
JTOWER Inc. is a telecommunications infrastructure company based in Tokyo, Japan, specializing in infrastructure sharing services. Founded in 2012, the company focuses on the design and construction of information communication infrastructure, as well as the development of communication-related solutions. JTOWER provides a range of services that include in-building infrastructure sharing, cloud-managed Wi-Fi, outdoor tower sharing, and local 5G services, catering primarily to landlords and mobile network operators. Additionally, it offers site locator systems to facilitate the deployment of mobile infrastructure. As a subsidiary of Nippon Telegraph and Telephone Corporation, JTOWER plays a vital role in enhancing telecommunications infrastructure across Japan.

Research and Innovation

Venture Round in 2014
Research and Innovation Co., Ltd. is a market research company based in Tokyo, Japan, established in 2011. It specializes in providing marketing research, sales promotion, and information services through the Internet. The company offers a range of services, including barcode research and promotion, brand image association surveys, and investigations into consumer interests. It conducts in-store and street surveys targeting foreign tourists in Japan and serves a diverse clientele across various sectors, including food, beauty, retail, finance, and media. Additionally, Research and Innovation develops tools that analyze consumer purchasing behavior, helping businesses gain insights into promotional effectiveness and market trends, thereby facilitating revenue growth and strategic decision-making.

Looop

Seed Round in 2014
Looop Inc. is a renewable energy company based in Tokyo, Japan, established in 2011. It specializes in the construction, development, and maintenance of solar power generation systems. By managing the entire value chain, Looop aims to reduce costs and facilitate the transition to renewable energy for its customers. The company offers a range of services including the development and sales of photovoltaic power stations, construction of solar facilities, and the operation of re-energized power plants. Looop's mission is to promote sustainable living by making renewable energy accessible and hassle-free for its clients.

gumi

Series H in 2014
Gumi Inc. is a Tokyo-based entertainment company established in 2007, specializing in the development, operation, and distribution of online games for mobile devices. The company has expanded its reach beyond Japan, establishing subsidiaries across Asia, Europe, and North America. Gumi offers a variety of gaming experiences, including native applications and browser-based games, while also providing publishing services that involve localizing third-party game content for various markets. In addition to its core gaming business, Gumi is involved in emerging technologies, including virtual reality, augmented reality, and mixed reality, reflecting its commitment to innovation in the entertainment sector.

GlyTech

Series A in 2014
GlyTech, Inc. specializes in the production of human-type N-glycans and the development of glycosylation technologies, including glycopeptide and glycoprotein synthesis. Founded in 2012 and based in Kyoto, Japan, the company focuses on enhancing the development of biopharmaceuticals and oligonucleotide therapeutics through innovative glycan production techniques. GlyTech offers a range of services, including custom synthesis, contract research and development, and the licensing of glycosylated peptides and proteins. Additionally, the company supplies standard reagents, supporting researchers in their efforts to advance human health by expanding their capabilities in glycoscience research and biotherapeutic analysis.

gumi

Series G in 2013
Gumi Inc. is a Tokyo-based entertainment company established in 2007, specializing in the development, operation, and distribution of online games for mobile devices. The company has expanded its reach beyond Japan, establishing subsidiaries across Asia, Europe, and North America. Gumi offers a variety of gaming experiences, including native applications and browser-based games, while also providing publishing services that involve localizing third-party game content for various markets. In addition to its core gaming business, Gumi is involved in emerging technologies, including virtual reality, augmented reality, and mixed reality, reflecting its commitment to innovation in the entertainment sector.

CMerTV Japan

Venture Round in 2013
CMer TV provides video adverts to each and every location via its own private network and enables video branding. It interacts with platforms and media in a variety of real-world contexts. They offer a platform for video advertising that works online and offline.

Siglead

Venture Round in 2013
Siglead Inc. is a company based in Yokohama, Japan, founded in 2007, specializing in the research and development of signal processing algorithms and related technologies. The company focuses on creating signal processing LSI (large scale integration) units and intellectual property, particularly for solid-state drives (SSDs). Siglead is known for its development of error correction methods for SSDs and NAND flash memory, as well as the design of SSD controller LSI, which enhances the reliability and performance of these storage solutions. Their product offerings include the SigNAS series of NAND flash memory testers, which incorporate advanced evaluation and error analysis technologies. These products are tailored to meet user needs and support a broad range of NAND flash generations, ultimately aiming to improve the efficiency of product cycles associated with NAND flash memory.

Marketing Applications

Venture Round in 2012
Marketing Applications is an IT solution vendor in the marketing research field, we provide a platform and operation resources to support researchers,including a questionnaire system for surveys and tabulation . No.1 research platform in Japan that is used by more than 200 companies, including research companies, consumer goods manufacturers, and advertising agencies .

Octoba

Venture Round in 2012
Octoba Inc. is a Tokyo-based company founded in June 2004, specializing in the planning, development, and operation of smartphone applications. With a strong media presence since 2009, Octoba has introduced tens of thousands of applications through its platform, which includes an online review site that provides essential information for Android users. This platform facilitates the discovery and usage of various applications, enhancing the experience for users seeking mobile solutions.

gumi

Series F in 2011
Gumi Inc. is a Tokyo-based entertainment company established in 2007, specializing in the development, operation, and distribution of online games for mobile devices. The company has expanded its reach beyond Japan, establishing subsidiaries across Asia, Europe, and North America. Gumi offers a variety of gaming experiences, including native applications and browser-based games, while also providing publishing services that involve localizing third-party game content for various markets. In addition to its core gaming business, Gumi is involved in emerging technologies, including virtual reality, augmented reality, and mixed reality, reflecting its commitment to innovation in the entertainment sector.

Tella

Venture Round in 2011
Tella, Inc. is a biotechnology company based in Tokyo, Japan, focused on the research and development of regenerative and cell-based medicines, particularly dendritic cell vaccine therapy for cancer treatment. The company collaborates with medical institutions to offer operational expertise and techniques related to this therapy. Tella provides comprehensive consultation services, assisting in the establishment and maintenance of cell processing centers and management systems for cell cultivation. Additionally, it offers training for cell cultivation technicians and support for the assessment of therapies, including necessary documentation and educational resources for physicians and patients. Founded in 2004, Tella is dedicated to advancing cancer treatment through innovative immune-based therapies.

KnowledgeSuite

Venture Round in 2010
KnowledgeSuite engages in developing SaaS business applications in Japan.

Berg Earth

Venture Round in 2010
Berg Earth Co Ltd is a Japan-based agribusiness company specializing in the production and sale of vegetable seedlings. The company primarily focuses on grafted seedlings of various fruits and vegetables, catering to the agricultural needs of its clientele. In addition to its seedling offerings, Berg Earth engages in the purchase and sale of agricultural products and materials, contributing to the broader agricultural supply chain. Its diverse product range includes various types of seedlings designed to meet different farming requirements.

Full Speed

Post in 2010
Full Speed Inc. is a Tokyo-based company specializing in internet marketing support services in Japan. Established in 2001, it offers a comprehensive range of services including search engine optimization (SEO), listing and affiliate advertising, display advertisements, and social media advertising. The company's diverse operations are categorized into several segments: the Internet Advertising Agency focuses on listing advertising and search engine marketing solutions, while the Ad Network segment integrates various website advertising spots for effective advertisement delivery. Additionally, the Information Media segment plans and creates information sites and e-commerce platforms, and the Creative segment provides website and banner creation services. Full Speed also offers consulting in SEO and social media operations, as well as services related to advertisement effect measurement and healthcare marketing. Full Speed Inc. is a subsidiary of FreeBit Co., Ltd.

MonotaRO

Post in 2010
MonotaRO Co. is a Japanese e-Commerce company of industrial supply products based in Hyogo, Japan.

Aisei Pharmacy

Seed Round in 2010
Aisei Pharmacy engages in the retail sales of prescription drugs, proprietary drugs, and non-prescription medicines. It has a network of dispensing pharmacies with more than 350 stores nationwide and accepts prescriptions from either medical institution. It was founded in September 1984 and is located in Marunouchi Chiyoda-ku , Tokyo, Japan.

All Ads

Venture Round in 2008
All Ads is a Tokyo-based company that specializes in digital marketing services aimed at enhancing the cost-effectiveness of advertising for business professionals. By focusing on LTV marketing, All Ads combines data, technology, and consulting to optimize advertising strategies. The company provides a range of services including in-house media management, affiliate advertising consulting, operational advertising consulting, and roundtable discussions. Through its comprehensive approach, All Ads seeks to support the growth of its clients' businesses by improving their advertising performance.

Cyberdyne

Seed Round in 2007
CYBERDYNE Inc. is a venture firm which is established by Dr. Yoshiyuki Sankai, University of Tsukuba, Japan, in order to materialize his idea to utilize Robot Suit HAL® for the benefits of humankind in the field of medicine, caregiving, welfare, labor, heavy works, entertainment and so on. Robot Suit HAL® was developed with the technologies created in Sankai Laboratory of Tsukuba University as an application of “Cybernics*” advocated by Prof. Sankai.

Emergency Assistance Japan

Venture Round in 2007
Emergency Assistance Japan Co., Ltd., founded in 2003 and headquartered in Tokyo, offers a range of medical and lifestyle assistance services both within Japan and internationally. The company specializes in medical and security assistance programs, including support for overseas students and lifestyle services. It also provides emergency response services and assistance tailored for foreign nationals. By focusing on comprehensive risk management and coordination, Emergency Assistance Japan aims to ensure the safety and well-being of individuals while traveling or residing abroad.

Gene Techno Science

Seed Round in 2004
Gene Techno Science is engaged in the research and development of biopharmaceutical products and biosimilars in Japan. The company develops drugs for the treatment of immunological, cardiovascular, ophthalmic, infectious, and renal diseases as well as oncology drugs. It also offers Filgrastim for the treatment of cancer. Gene Techno Science was founded in 2001 and is headquartered in Sapporo, Japan.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.